Laboratory survey of prostate specific antigen testing in Ontario

Clinical Biochemistry

Volumn 31, Issue 1, 1998, Pages 47-49

  Bunting, Peter S ^a,b   Miyazaki, Joanne H ^c   Goel, Vivek ^a,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c Lab Proficiency Testing Program   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

Author keywords

Information systems; Laboratories; Prostate specific antigen; Utilization; Workload

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ARTICLE; CANADA; CLINICAL CHEMISTRY; CLINICAL LABORATORY; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; WORKLOAD;

FOLLOW-UP STUDIES; HUMANS; LABORATORIES; LABORATORIES, HOSPITAL; LONGITUDINAL STUDIES; MALE; ONTARIO; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUESTIONNAIRES;

EID: 0032008051     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(97)00141-0     Document Type: Article

References (11)

1. 1. Canadian Cancer Statistics 1995; National Cancer Institute of Canada.
2. 2. Levy IG, Gibbons L, Collins JP, Perkins DG, Mao Y. Prostate cancer trends in Canada: rising incidence or increased detection? Can Med Assoc J 1993; 149: 617-24.
3. 3. van Andel G, Vleeming R, Kurth K, de Reijke TM. Incidental carcinoma of the prostate. Sem Surg Oncol 1995; 11: 36-45.
4. 4. Mettlin C, Murphy GP, Babaian RJ, et al. The results of a five-year early prostate cancer detection intervention. Cancer 1996; 77: 150-9.
5. 5. Labrie F, Dupont A, Suburu R, et al. Serum prostate-specific antigen as a prescreening test for prostate cancer. J Urol 1992; 147: 846-52.
6. 6. Catalona WJ, Smith DS, Ratliff TL, Basler JW. Detection of organ confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 1993; 270: 948-54.
7. 7. Mercer S, Goel V, Levy I, Ashbury FD, Iverson DC, Iscoe NA. Prostate cancer screening in the midst of controversy. Canadian men's knowledge, beliefs, utilization and future intentions. Can J Pub Health 1997; 88: 327-332.
8. 8. The PSA test in the early detection of prostate cancer. Final report, February 1995. Health Services Utilization and Research Commission, Government of Saskatchewan.
9. 9. Screening for cancer of the prostate: an evaluation of benefits, unwanted health effects, and costs. Report prepared by Conseil d'evaluation des technologies de la sante du Quebec. August 1995.
10. 10. Laboratory Proficiency Testing Program. Ontario Medical Association, Endocrinology Committee, November 1995.
11. 11. Feeny D, Guyatt G, Tugwell P. Health care technology: effectiveness, efficiency and public policy. Institute for Research on Public Policy, 1996.